James Swanson to sell 20,521 Johnson & Johnson shares

Shareholder James Swanson filed a Rule 144 notice to sell 20,521 Johnson & Johnson common shares with an aggregate market value of $4,980,510.40.

Rhea-AI Filing Summary

Shareholder James Swanson filed a Rule 144 notice to sell 20,521 Johnson & Johnson common shares with an aggregate market value of $4,980,510.40. The shares are planned to be sold on the NYSE around 02/17/2026 through Fidelity Brokerage Services LLC.

These shares were acquired on 02/17/2026 via options granted on 02/08/2021, with the 20,521 shares paid for in cash. Over the prior three months, Swanson sold 41,559 Johnson & Johnson common shares on 02/13/2026 for gross proceeds of $10,129,245.92.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing reveal about Johnson & Johnson (JNJ)?

The filing shows shareholder James Swanson intends to sell 20,521 Johnson & Johnson common shares, valued at $4,980,510.40. It also discloses a prior sale of 41,559 shares for $10,129,245.92 within the last three months.

How many Johnson & Johnson (JNJ) shares is James Swanson planning to sell?

James Swanson plans to sell 20,521 Johnson & Johnson common shares. The aggregate market value of this planned sale is reported as $4,980,510.40, based on information included in the Rule 144 notice for an NYSE transaction through Fidelity Brokerage Services LLC.

When are the planned Johnson & Johnson (JNJ) share sales expected to occur?

The Rule 144 notice lists an approximate sale date of 02/17/2026 for 20,521 Johnson & Johnson common shares. A prior sale of 41,559 shares occurred on 02/13/2026, indicating recent and upcoming transactions in close succession for this shareholder.

How were the Johnson & Johnson (JNJ) shares in the Form 144 acquired?

The 20,521 Johnson & Johnson common shares were acquired on 02/17/2026 through options granted on 02/08/2021. The filing states the shares were obtained from the issuer and paid for in cash at the time of acquisition.

What prior Johnson & Johnson (JNJ) share sales has James Swanson reported?

Over the past three months, James Swanson sold 41,559 Johnson & Johnson common shares on 02/13/2026. The gross proceeds from this earlier transaction were $10,129,245.92, as detailed in the section covering securities sold during the past three months.

Through which broker will the Johnson & Johnson (JNJ) shares be sold under this Form 144?

The planned sale of 20,521 Johnson & Johnson common shares will be executed through Fidelity Brokerage Services LLC. The filing lists Fidelity’s Smithfield, Rhode Island address and specifies that the securities are expected to be sold on the NYSE around 02/17/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 02:52 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001904785
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	JOHNSON & JOHNSON
SEC File Number	001-03215
Address of Issuer	ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NEW JERSEY 08933
Phone	732-524-2455
Name of Person for Whose Account the Securities are To Be Sold	Swanson James D.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	20521	4980510.40	2409898936	02/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/17/2026	Options Granted - 02/08/2021	Issuer			20521	02/17/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James Swanson One Johnson & Johnson Plaza New Brunswick NJ 08933	Common	02/13/2026	41559	10129245.92

144: Remarks and Signature

Remarks
Date of Notice	02/17/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for James Swanson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)